Gynecomastia: When is treatment indicated?

Title

Gynecomastia: When is treatment indicated?

Creator

Morcos RN; Kizy T

Publisher

Journal of Family Practice

Date

2012
2012-12

Subject

Male; Magnetic Resonance Imaging; Age Factors; Clinical Trials; Middle Age; Disease Management; Patient History Taking – Methods; Drug Toxicity – Etiology; Drug Toxicity – Metabolism; Drug Toxicity – Physiopathology; Gynecomastia – Etiology; Gynecomastia – Metabolism; Gynecomastia – Physiopathology; Gynecomastia – Therapy; Physical Examination – Methods; Pituitary Gland – Metabolism; Pituitary Gland – Pathology; Pituitary Neoplasms – Complications; Pituitary Neoplasms – Diagnosis; Pituitary Neoplasms – Metabolism; Prolactin – Metabolism; Prolactinoma – Complications; Prolactinoma – Diagnosis; Prolactinoma – Metabolism; Sex Hormones – Metabolism; Sex Hormones – Therapeutic Use

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

719–725

Issue

12

Volume

61

Citation

Morcos RN; Kizy T, “Gynecomastia: When is treatment indicated?,” NEOMED Bibliography Database, accessed March 28, 2024, https://neomed.omeka.net/items/show/5951.